Opioid and Stimulant Overdose Reporting Program to Expand Under Increased Federal Funding Phoenix, AZ, Oct. 17, 2023 (GLOBE NEWSWIRE) -- In September of 2022, the FDA awarded the American College of Medical Toxicology’s (ACMT) Toxicology Investigators Consortium (ToxIC) a 5-year $7.9...

Fentanyl, Xylazine, Cannabinoids to Feature in Virtual Forensic Toxicology Seminar December 14 - 15, 2023 Phoenix, AZ, Oct. 16, 2023 (GLOBE NEWSWIRE) -- The American College of Medical Toxicology (ACMT) and the Center for Forensic Science Research and Education (CFSRE) are pleased to offer a two-day...

Gravity Diagnostics Expands Testing Services to Include Xylazine Detection: A Crucial Advancement in Ensuring Public Safety Covington, KY, Sept. 20, 2023 (GLOBE NEWSWIRE) -- **FOR IMMEDIATE RELEASE** [[Covington, KY] – [9/20/23] – Gravity Diagnostics, a leading clinical toxicology laboratory, is announcing a...

Oxford Treatment Center Issues Warning on Increasing Presence of Xylazine OXFORD, Miss., July 05, 2023 (GLOBE NEWSWIRE) -- Oxford Treatment Center, a leading provider of substance use and co-occurring mental health treatment in Mississippi, is warning residents about the...

CDC Launches Fentanyl Dashboard Utilizing Data from the Toxicology Investigators Consortium (ToxIC) to Monitor Nonfatal Overdose Trends Phoenix, AZ, June 09, 2023 (GLOBE NEWSWIRE) -- Fentanyl, a powerful synthetic opioid, has emerged as a significant public health concern across the United States, contributing to a surge in...